Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/global-mapping-of-pharmacological-space-W2LwThC7X8
References (56)
-
A. Schuffenhauer, E. Jacoby (2004)
Annotating and mining the ligand-target chemogenomics knowledge spaceDrug Discovery Today: Biosilico, 2
-
James Golden (2003)
Prioritizing the human genome: knowledge management for drug discovery.Current opinion in drug discovery & development, 6 3
-
E. Roth, W. Pedrycz, R. Kruse, J. Hyun (2002)
Handbook of Data Mining and Knowledge Discovery -
Thomas Connolly, Carolyn Begg (1998)
Database Systems: A Practical Approach to Design, Implementation and Management -
H. Feldman, M. Dumontier, S. Ling, N. Haider, C. Hogue (2005)
CO: A chemical ontology for identification of functional groups and semantic comparison of small moleculesFEBS Letters, 579
-
S. Frantz (2005)
Playing dirtyNature, 437
-
B. Stockwell (2000)
Chemical genetics: ligand-based discovery of gene functionNature Reviews Genetics, 1
-
J. Proudfoot (2002)
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs.Bioorganic & medicinal chemistry letters, 12 12
-
P. Andrews, D. Craik, J. Martín (1984)
Functional group contributions to drug-receptor interactions.Journal of medicinal chemistry, 27 12
-
J. Weinstein, T. Myers, P. O'Connor, S. Friend, A. Fornace, K. Kohn, T. Fojo, S. Bates, L. Rubinstein, N. Anderson, J. Buolamwini, W. Osdol, A. Monks, D. Scudiero, E. Sausville, D. Zaharevitz, B. Bunow, V. Viswanadhan, G. Johnson, R. Wittes, K. Paull (1997)
An Information-Intensive Approach to the Molecular Pharmacology of CancerScience, 275
-
S. Frye (1999)
Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era.Chemistry & biology, 6 1
-
A. Hopkins, C. Groom (2002)
The druggable genomeNature Reviews Drug Discovery, 1
-
W. Walters, Ajay Murcko, M. Murcko (1999)
Recognizing molecules with drug-like properties.Current opinion in chemical biology, 3 4
-
C. Krejsa, D. Horvath, Sherri Rogalski, J. Penzotti, Boryeu Mao, F. Barbosa, J. Migeon (2003)
Predicting ADME properties and side effects: the BioPrint approach.Current opinion in drug discovery & development, 6 4
-
C. Lipinski (2000)
Drug-like properties and the causes of poor solubility and poor permeability.Journal of pharmacological and toxicological methods, 44 1
-
W. Egan, W. Walters, M. Murcko (2002)
Guiding molecules towards drug-likeness.Current opinion in drug discovery & development, 5 4
-
J. Drews, S. Ryser (1997)
Classic drug targetsNature Biotechnology, 15
-
A. Wallqvist, A. Monks, A. Rabow, N. Thanki, R. Shoemaker, D. Covell (2003)
Mining the NCI screening database: explorations of agents involved in cell cycle regulation.Progress in cell cycle research, 5
-
A. Schuffenhauer, J. Zimmermann, Ruedi Stoop, J. Vyver, S. Lecchini, E. Jacoby (2002)
An Ontology for Pharmaceutical Ligands and Its Application for in Silico Screening and Library DesignJournal of chemical information and computer sciences, 42 4
-
J. Drews, S. Ryser (1997)
Drug Development: The role of innovation in drug developmentNature Biotechnology, 15
-
Jörg Rech (2001)
Knowledge Discovery in DatabasesKünstliche Intell., 15
-
A. Hopkins, C. Groom, A. Alex (2004)
Ligand efficiency: a useful metric for lead selection.Drug discovery today, 9 10
-
W.Patrick Walters, M. Murcko (2002)
Prediction of 'drug-likeness'.Advanced drug delivery reviews, 54 3
-
I. Muegge, S. Heald, D. Brittelli (2001)
Simple selection criteria for drug-like chemical matter.Journal of medicinal chemistry, 44 12
-
Jing Wang, K. Ramnarayan (1999)
Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds.Journal of combinatorial chemistry, 1 6
-
Xiaoyang Xia, E. Maliski, P. Gallant, David Rogers (2004)
Classification of kinase inhibitors using a Bayesian model.Journal of medicinal chemistry, 47 18
-
S Frantz (2005)
Drug discovery: playing dirtyNature, 437
-
David Kushner (2007)
Playing DirtyIEEE Spectrum, 44
-
M. Vieth, R. Higgs, D. Robertson, M. Shapiro, Ellen Gragg, H. Hemmerle (2004)
Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.Biochimica et biophysica acta, 1697 1-2
-
M. Wenlock, R. Austin, P. Barton, A. Davis, P. Leeson (2003)
A comparison of physiochemical property profiles of development and marketed oral drugs.Journal of medicinal chemistry, 46 7
-
D. Root, Stephen Flaherty, B. Kelley, B. Stockwell (2003)
Biological mechanism profiling using an annotated compound library.Chemistry & biology, 10 9
-
J. Blake (2003)
Examination of the computed molecular properties of compounds selected for clinical development.BioTechniques, Suppl
-
C. Austin, L. Brady, T. Insel, F. Collins (2004)
NIH Molecular Libraries InitiativeScience, 306
-
Paul Shannon, Andrew Markiel, Owen Ozier, N. Baliga, Jonathan Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, T. Ideker (2003)
Cytoscape: a software environment for integrated models of biomolecular interaction networks.Genome research, 13 11
-
C. Lipinski, A. Hopkins (2004)
Navigating chemical space for biology and medicineNature, 432
-
Brent Podlogar, I. Muegge, Brice Lj (2001)
Computational methods to estimate drug development parameters.Current opinion in drug discovery & development, 4 1
-
I. Kuntz, K. Chen, K. Sharp, P. Kollman (1999)
The maximal affinity of ligands.Proceedings of the National Academy of Sciences of the United States of America, 96 18
-
C. Lipinski, F. Lombardo, B. Dominy, P. Feeney (2001)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Advanced drug delivery reviews, 46 1-3
-
M. Vieth, M. Siegel, R. Higgs, Ian Watson, D. Robertson, K. Savin, G. Durst, P. Hipskind (2004)
Characteristic physical properties and structural fragments of marketed oral drugs.Journal of medicinal chemistry, 47 1
-
M. Vieth, J. Sutherland, D. Robertson, R. Campbell (2005)
Kinomics: characterizing the therapeutically validated kinase space.Drug discovery today, 10 12
-
J. Drews (1996)
Genomic sciences and the medicine of tomorrowNature Biotechnology, 14
-
(2005)
Development Team. A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna -
Ajay, and Walters, M. Murcko (1998)
Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?Journal of medicinal chemistry, 41 18
-
Gregory Piateski, W. Frawley (1991)
Knowledge Discovery in Databases -
B. Roth, D. Sheffler, W. Kroeze (2004)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophreniaNature Reviews Drug Discovery, 3
-
I. Muegge (2003)
Selection criteria for drug‐like compoundsMedicinal Research Reviews, 23
-
S. Gestel, V. Schuermans (1986)
Thirty‐three years of drug discovery and research with Dr. Paul JanssenDrug Development Research, 8
-
David Rogers, Robert Brown, M. Hahn (2005)
Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-UpJournal of Biomolecular Screening, 10
-
C. Wermuth (2004)
Selective optimization of side activities: another way for drug discovery.Journal of medicinal chemistry, 47 6
-
R. Strausberg, S. Schreiber (2003)
From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule ProbesScience, 300
-
S. McGovern, B. Helfand, Brian Feng, B. Shoichet (2003)
A specific mechanism of nonspecific inhibition.Journal of medicinal chemistry, 46 20
-
W. Sneader (1996)
Drug prototypes and their exploitation -
D. Veber, Stephen Johnson, Hung‐Yuan Cheng, B. Smith, K. Ward, K. Kopple (2002)
Molecular properties that influence the oral bioavailability of drug candidates.Journal of medicinal chemistry, 45 12
-
M. Lajiness, M. Vieth, J. Erickson (2004)
Molecular properties that influence oral drug-like behavior.Current opinion in drug discovery & development, 7 4
-
D. Horvath, C. Jeandenans (2003)
Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding ProfilesJournal of chemical information and computer sciences, 43 2
-
B. Roth, E. Lopez, Shamil Patel, W. Kroeze (2000)
The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?The Neuroscientist, 6
- Publisher
- Springer Journals
- Copyright
- Copyright © 2006 by Nature Publishing Group
- Subject
- Life Sciences; Life Sciences, general; Biotechnology; Biomedicine, general; Agriculture; Biomedical Engineering/Biotechnology; Bioinformatics
- ISSN
- 1087-0156
- eISSN
- 1546-1696
- DOI
- 10.1038/nbt1228
- Publisher site
- See Article on Publisher Site
Abstract
We present the global mapping of pharmacological space by the integration of several vast sources of medicinal chemistry structure-activity relationships (SAR) data. Our comprehensive mapping of pharmacological space enables us to identify confidently the human targets for which chemical tools and drugs have been discovered to date. The integration of SAR data from diverse sources by unique canonical chemical structure, protein sequence and disease indication enables the construction of a ligand-target matrix to explore the global relationships between chemical structure and biological targets. Using the data matrix, we are able to catalog the links between proteins in chemical space as a polypharmacology interaction network. We demonstrate that probabilistic models can be used to predict pharmacology from a large knowledge base. The relationships between proteins, chemical structures and drug-like properties provide a framework for developing a probabilistic approach to drug discovery that can be exploited to increase research productivity.
Journal
Nature Biotechnology – Springer Journals
Published: Jul 13, 2006